Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001802440 | SCV002048492 | pathogenic | Hereditary factor VIII deficiency disease | 2021-04-06 | criteria provided, single submitter | clinical testing | The F8 c.5501dupA; p.Tyr1834Ter variant, also known as p.Tyr1815Ter, is reported in the literature in multiple individuals affected with severe hemophilia A (Factor VIII database, Sanna 2008, Santacroce 2008). This variant is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Factor VIII database: https://f8-db.eahad.org/index.php Sanna V et al. Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A patients from Southern Italy. Haemophilia. 2008 Jul;14(4):796-803. PMID: 18459951. Santacroce R et al. Identification of 217 unreported mutations in the F8 gene in a group of 1,410 unselected Italian patients with hemophilia A. J Hum Genet. 2008;53(3):275-284. PMID: 18217193. |